Getting your ADCs to the clinic: Consideration for early stage development

Date: 02-Dec-13 to 02-Dec-13
Location: Holiday Inn Bloomsbury / London / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

The development of existing or novel monoclonal antibodies as drug-conjugates to increase the targeted clinical effect of these proteins has rapidly increased in recent years. Over 30 antibody–drug conjugates (ADCs) are being tested in the clinic in a range of oncology indications.

SMi's masterclass hosted by PAREXEL International will discuss ADCs which are being tested in the clinic in a range of oncology indications. In the absence of specific guidance on the development of ADCs, this workshop aims to help participants understand the CMC issues during the development, with a particular focus on the assessment and control of the quality of such products.

Timing: 8:30 am to 1:30 pm.

Price: £599

Visitors

Everybody

Exhibitors

Parexel International, Isabel Zwart, Alex Bloom.

Go to event website